Lockheed Martin heads into the week of September 15 with a notable tension: the Street has turned more constructive just as the stock has shed more than 12% over the past month, leaving bulls and bears debating whether the selloff is an opportunity or a warning.
The most significant development on the Street came on September 8, when UBS upgraded LMT to Buy from Neutral and lifted its target to $674 — a move that stands out given the stock closed Tuesday at $533.46. That upgrade follows a string of upward target revisions post-Q2 earnings in late July, with Citigroup lifting to $691 and Morgan Stanley moving to $690, both maintaining their existing ratings. The analyst consensus remains a Hold — 6 buys against 12 holds — and the mean price target of $638 implies roughly 20% upside from current levels. The bull case centers on exceptional Q4 2025 cash flow, a pre-funded 2026 pension obligation, and FCF guidance raised by more than 10%. Bears point to the loss of the NGAD next-generation fighter program, ongoing F-35 uncertainty, and the structural risk that a federal budget deal could cap defense outlays. The divergence between the hold-weighted consensus and the $100-plus gap to the mean target is itself the story: the Street sees value, but not enough conviction to chase it aggressively.
Options positioning is mildly constructive, not alarmed. The put/call ratio of 0.80 runs slightly below its 20-day average of 0.85 — a reading that has drifted from near 1.04 in early August down toward the middle of the year's range. That shift from defensive hedging toward a more neutral stance tracks the broader re-rating narrative: investors are becoming less worried, not more, even as the stock has underperformed. The 52-week PCR range of 0.47 to 1.04 puts the current reading in the calmer half of the distribution.
Short interest tells an unexciting story, and that is worth saying plainly. Shorts hold just 1.2% of the free float — a structurally low level for a mega-cap defense name. The week-on-week rise of 12% in share count sounds alarming but reflects a jump from roughly 2.4 million to 2.7 million shares, a modest absolute move against a multi-billion-dollar float. Borrow conditions are loose: cost to borrow has eased 16% over the week to 0.41%, and availability is extraordinarily deep, with more than 132 million shares available against current short interest. There is no squeeze dynamic here, no borrow tightness, no short-driven pressure on the price. The 12% monthly decline is a fundamental story, not a short story.
The recent earnings history adds relevant texture. When Lockheed reported Q2 2026 results in late July, the stock jumped 13.3% on the day and held most of that gain over the following week, finishing the five-day window up 11.6%. That was a sharp reversal from the pattern seen after Q1, where the one-day move was a muted +0.9% before a 14% five-day rally. Both reactions were positive and substantial. Q3 2026 results are scheduled for October 20 — the next concrete catalyst on the calendar.
The peer comparison sharpens the recent underperformance. NOC gained 2.4% on the week. European defense names ran harder still, with Thales (HO) up 3.1% and Airbus (AM) up 2.8%. RTX slipped 1.7% and LHX fell 2.4%, so LMT's flat-to-slight-down week is not universally shared across US defense, but the divergence is not extreme. Whether the October earnings print can close the gap between a $533 price and a $638 Street consensus is the question the market will spend the next five weeks answering.
See the live data behind this article on ORTEX.
Open LMT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
